Cerevel Therapeutics

Cerevel, in ‘major surprise,’ finds success in late-stage Parkinson’s study
BioPharma Dive
Thu, 04/18/24 - 11:09 am
Cerevel Therapeutics
Parkinson's Disease
tavapadon
Psychosis: The Other Big Alzheimer’s Therapeutic Target
BioSpace
Tue, 04/2/24 - 11:46 am
Alzheimer's disease
Alzheimer's disease psychosis
Cerevel Therapeutics
Karuna Therapeutics
AbbVie’s Cerevel deal hits an uncommon roadblock
BioPharma Dive
Wed, 02/21/24 - 11:10 am
AbbVie
Cerevel Therapeutics
M&A
FTC
antitrust
Karuna, Cerevel might be just the start of psychiatry drug M&A
BioPharma Dive
Tue, 01/23/24 - 11:17 am
M&A
Karuna Therapeutics
Cerevel Therapeutics
schizophrenia
AbbVie
Bristol Myers Squibb
All AbbVie's CEO wanted for Christmas was Cerevel—oh, and ImmunoGen, too
Fierce Biotech
Mon, 01/8/24 - 11:30 am
AbbVie
Richard Gonzalez
Cerevel Therapeutics
M&A
AbbVie CEO Gonzalez brushes off FTC concerns for Cerevel buy: 'This acquisition is not anti-competitive.'
Fierce Biotech
Thu, 12/7/23 - 11:08 pm
AbbVie
Cerevel Therapeutics
M&A
Richard Gonzalez
FTC
anticompetitive practices
AbbVie to buy Cerevel in $8.7B bet on brain drugs
BioPharma Dive
Wed, 12/6/23 - 09:23 pm
AbbVie
Cerevel Therapeutics
M&A
Neuroscience
The Neuropsychiatric Pipeline: 10 Late-Stage Therapies to Watch
BioSpace
Mon, 08/14/23 - 11:23 am
depression
Biogen
SAGE Therapeutics
zuranolone
Intra-Cellular Therapies
lumateperone
Alto Neuroscience
ALTO-100
schizophrenia
Karuna Therapeutics
KarXT
Cerevel Therapeutics
emraclidine
Acadia Pharmaceuticals
pimavanserin
Axesome Therapeutics
AXS-05
Alzheimer's agitation
NRx
NRX-101
bipolar disorder
Biohaven
troriluzole
OCD
VistaGen
fasedienol
social anxiety
Google Cloud launches A.I.-powered tools to accelerate drug discovery, precision medicine
CNBC
Wed, 05/17/23 - 10:05 am
Google
Google Cloud
artificial intelligence
drug discovery
precision medicine
Pfizer
Colossal Biosciences
Cerevel Therapeutics
Cerevel to change up CEO as 7 data readouts near showdown
Fierce Biotech
Thu, 05/4/23 - 09:13 am
Cerevel Therapeutics
Pharma CEOs
Tony Coles
Neurosciences
clinical trials
IPOs vs SPACs
EP Vantage
Thu, 03/9/23 - 09:47 am
IPOs
SPAC
Belite Bio
Cerevel Therapeutics
NewAmsterdam Pharma
Nuvectis Pharma
Oculis
Roivant Sciences
Cerevel blames Covid for delayed neuroscience studies, says president is leaving
Endpoints
Fri, 02/24/23 - 09:12 am
Cerevel Therapeutics
COVID-19
epilepsy
Parkinson's Disease
darigabat
CVL-871
How 2 biotechs survived 2022’s rocky market—and why their CEOs see success on the horizon
Fierce Biotech
Wed, 01/18/23 - 11:12 pm
Agios Pharmaceuticals
Cerevel Therapeutics
JPMHC 2023
layoffs
Pfizer's neuroscience spinout scores in schizophrenia
BioPharma Dive
Wed, 06/30/21 - 12:05 am
Cerevel Therapeutics
Pfizer
schizophrenia
clinical trials
Cerevel Therapeutics Announces Strategic $125 Million Non-Dilutive Financing Transaction for Tavapadon
BioSpace
Tue, 04/13/21 - 10:17 am
Cerevel Therapeutics
Parkinson's Disease
tavapadon
Bain Capital
Novaquest
Pfizer Spinoff Cerevel Therapeutics Begins Trading on the Nasdaq
BioSpace
Wed, 10/28/20 - 11:09 pm
Pfizer
Cerevel Therapeutics
SPAC
Arya Sciences
NASDAQ
Pfizer spinoff Cerevel to raise $445M in merger with blank-check company
BioPharma Dive
Thu, 07/30/20 - 11:15 pm
Cerevel Therapeutics
Pfizer
M&A
SPAC
special purpose acquisition company
Cerevel plots first late-stage move as Pfizer drug comes through in PhII Parkinson's trial
Endpoints
Tue, 09/24/19 - 11:08 am
Cerevel Therapeutics
Pfizer
clinical trials
Parkinson's Disease
tavapadon
Pfizer spinout Cerevel hires Coles as CEO
Fierce Biotech
Mon, 09/9/19 - 10:34 am
Tony Coles
Cerevel Therapeutics
Pfizer
Pharma CEOs
Neuroscience
Pfizer CNS spinout Cerevel brings on new CMO to launch phase 3 work in Parkinson’s disease
Fierce Biotech
Wed, 02/20/19 - 06:09 pm
Cerevel Therapeutics
Pfizer
Otsuka
CMOs
Parkinson's Disease
epilepsy

Pages